Show notes
Until only recently, treating Glioblastoma brain cancer with chemotherapy has not been achievable due to the blood brain barrier. In today’s Bindwaves episode, Dr. Michael Canney walks us through how Carthera developed a revolutionary method to deliver therapeutics to the brain utilizing an ultrasound system. It is well known that the survival rate for Glioblastoma is 1 to 2 years. Surgery tends to be the primary means to combat this horrible disease. To improve these ...
